Skip to main content

HCA Healthcare, Inc. statistics

  • HCA · NYSE
  • Healthcare
  • Health Care Facilities
  • S&P 500
$499.05−0.32%Close 13 Nov 2026 · Market value $107.0B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

HCA Healthcare, Inc. is valued at $107.0B on its latest close. Its price is 15.8 times its earnings.

Market value$107.0B
Enterprise value$160.2B
Price / earnings15.80
Price / sales1.36
EV / EBITDA10.11
EV / sales2.04
Price / free cash flow17.92
Price / free cash flow, own 5-year average15.58
EV / EBIT13.09
EV / free cash flow26.54
Free cash flow yield5.6%
Dividend yield0.6%

Share price

Latest close$499.05
Day's change−0.3%
52-week high$556.52
52-week low$353.99
From 52-week high−10.3%
Return · 1 month+8.8%
Return · 3 months+22.8%
Return · year to date+6.9%
Return · 1 year+5.4%
Beta · 1 year against the S&P 5000.28
50-day average$452.77
200-day average$445.32
RSI 1461.2
Average volume · 20 sessions1.4M

Margins and returns

For fiscal 2025, as filed.

Operating margin15.9%
Net margin9.0%
Free cash flow margin10.2%
Return on assets15.8%
Return on invested capital19.4%
Return on invested capital, 5-year average19.4%
Return on capital employed27.1%
Stock-based compensation / revenue0.5%

Financial position

At the end of fiscal 2025.

Cash and equivalents$1.04B
Total debt$48.70B
Net debt$47.66B
Current ratio0.97
Quick ratio0.63
Net debt / EBITDA3.07
Interest coverage5.34

Growth

Revenue, latest quarter on a year+3.6%
Revenue, twelve months on a year+5.8%
EPS, latest quarter on a year+4.5%
EPS, twelve months on a year+17.0%
Revenue, 5-year compound+8.0%
Revenue, 10-year compound+6.7%
Net income, 5-year compound+12.6%
Free cash flow, 5-year compound+3.8%
EPS, 5-year compound+21.0%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares239M
Shares outstanding, 5-year compound−7.0%
Net share repurchases$10.07B
Dividends per share$2.88
Dividend payout10.0%

Taxes

For fiscal 2025, as filed.

Income tax expense$2.05B
Effective tax rate20.9%

HCA in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.